Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization

Journal of Molecular Biology

Volumn 350, Issue 4, 2005, Pages 699-712

  Hu, Qinxue ^a,b   Napier, Kelby B ^c   Trent, John O ^c   Wang, Zixuan ^d   Taylor, Stephen ^e   Griffin, George E ^a   Peiper, Stephen C ^d   Shattock, Robin J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CCR5; Envelope glycoprotein; HIV 1; Structure; V3 loop

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; RECEPTOR SUBTYPE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; DATA BASE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; INFECTION; MOLECULAR INTERACTION; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; T LYMPHOCYTE; VIRUS; WILD TYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 20544458737     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.05.024     Document Type: Article

References (52)

1. E.A. Berger, P.M. Murphy, and J.M. Farber Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu. Rev. Immunol. 17 1999 657 700
2. D.C. Chan, and P.S. Kim HIV entry and its inhibition Cell 93 1998 681 684
3. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J. Cell. Biol. 151 2000 F9 14
4. G. Scarlatti, E. Tresoldi, A. Bjorndal, R. Fredriksson, C. Colognesi, and H.K. Deng In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression Nature Med. 3 1997 1259 1265
5. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, and P.D. Ponath The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 85 1996 1135 1148
6. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, and R. Allikmets Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study Science 273 1996 1856 1862
7. Y. Huang, W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, and T. He The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nature Med. 2 1996 1240 1243
8. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, and R. Horuk Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367 377
9. M. Samson, F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, and C. Farber Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 1996 722 725
10. T. Dragic An overview of the determinants of CCR5 and CXCR4 co-receptor function J. Gen. Virol. 82 2001 1807 1814
11. B.J. Doranz, Z.H. Lu, J. Rucker, T.Y. Zhang, M. Sharron, and Y.H. Cen Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1 J. Virol. 71 1997 6305 6314
12. T. Dragic, A. Trkola, S.W. Lin, K.A. Nagashima, F. Kajumo, and L. Zhao Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry J. Virol. 72 1998 279 285
13. M. Farzan, H. Choe, L. Vaca, K. Martin, Y. Sun, and E. Desjardins A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5 J. Virol. 72 1998 1160 1164
14. C. Blanpain, B.J. Doranz, J. Vakili, J. Rucker, C. Govaerts, and S.S. Baik Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein J. Biol. Chem. 274 1999 34719 34727
15. Z. Wang, B. Lee, J.L. Murray, F. Bonneau, Y. Sun, and V. Schweickart CCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domains J. Biol. Chem. 274 1999 28413 28419
16. M. Samson, G. LaRosa, F. Libert, P. Paindavoine, M. Detheux, and G. Vassart The second extracellular loop of CCR5 is the major determinant of ligand specificity J. Biol. Chem. 272 1997 24934 24941
17. L. Wu, G. LaRosa, N. Kassam, C.J. Gordon, H. Heath, and N. Ruffing Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding J. Exp. Med. 186 1997 1373 1381
18. B. Lee, M. Sharron, C. Blanpain, B.J. Doranz, J. Vakili, and P. Setoh Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function J. Biol. Chem. 274 1999 9617 9626
19. W.C. Olson, G.E. Rabut, K.A. Nagashima, D.N. Tran, D.J. Anselma, and S.P. Monard Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5 J. Virol. 73 1999 4145 4155
20. T. Dragic, A. Trkola, D.A. Thompson, E.G. Cormier, F.A. Kajumo, and E. Maxwell A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5 Proc. Natl Acad. Sci. USA 97 2000 5639 5644
21. T.L. Hoffman, and R.W. Doms HIV-1 envelope determinants for cell tropism and chemokine receptor use Mol. Membr. Biol. 16 1999 57 65
22. B. Chesebro, K. Wehrly, J. Nishio, and S. Perryman Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism J. Virol. 66 1992 6547 6554
23. J.M. Rini, R.L. Stanfield, E.A. Stura, P.A. Salinas, A.T. Profy, and I.A. Wilson Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen Proc. Natl Acad. Sci. USA 90 1993 6325 6329
24. P. Catasti, J.D. Fontenot, E.M. Bradbury, and G. Gupta Local and global structural properties of the HIV-MN V3 loop J. Biol. Chem. 270 1995 2224 2232
25. P.D. Kwong, R. Wyatt, S. Majeed, J. Robinson, R.W. Sweet, J. Sodroski, and W.A. Hendrickson Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates Struct. Fold. Des. 8 2000 1329 1339
26. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski, and W.A. Hendrickson Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393 1998 648 659
27. R. Wyatt, and J. Sodroski The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens Science 280 1998 1884 1888
28. R. Wyatt, P.D. Kwong, E. Desjardins, R.W. Sweet, J. Robinson, W.A. Hendrickson, and J.G. Sodroski The antigenic structure of the HIV gp120 envelope glycoprotein Nature 393 1998 705 711
29. C.D. Rizzuto, R. Wyatt, N. Hernandez-Ramos, Y. Sun, P.D. Kwong, W.A. Hendrickson, and J. Sodroski A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280 1998 1949 1953
30. Q. Hu, J.O. Trent, G.D. Tomaras, Z. Wang, J.L. Murray, and S.M. Conolly Identification of Env determinants in V3 that influence the molecular anatomy of CCR5 utilization J. Mol. Biol. 302 2000 359 375
31. E.G. Cormier, and T. Dragic The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor J. Virol. 76 2002 8953 8957
32. E.G. Cormier, D.N. Tran, L. Yukhayeva, W.C. Olson, and T. Dragic Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes J. Virol. 75 2001 5541 5549
33. W.K. Wang, T. Dudek, M. Essex, and T.H. Lee Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications Proc. Natl Acad. Sci. USA 96 1999 4558 4562
34. W.K. Wang, T. Dudek, Y.J. Zhao, H.G. Brumblay, M. Essex, and T.H. Lee CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120 Proc. Natl Acad. Sci. USA 95 1998 5740 5745
35. Y. Yi, A. Singh, F. Shaheen, A. Louden, C. Lee, and R.G. Collman Contrasting use of CCR5 structural determinants by R5 and R5X4 variants within a human immunodeficiency virus type 1 primary isolate quasispecies J. Virol. 77 2003 12057 12066
36. F. Gao, S.G. Morrison, D.L. Robertson, C.L. Thornton, S. Craig, and G. Karlsson Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID networks for HIV isolation and characterization J. Virol. 70 1996 1651 1667
37. I. Karlsson, L. Antonsson, Y. Shi, M. Oberg, A. Karlsson, and J. Albert Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype J. Virol. 78 2004 11807 11815
38. F.A. Koning, D. Kwa, B. Boeser-Nunnink, J. Dekker, J. Vingerhoed, H. Hiemstra, and H. Schuitemaker Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection J. Infect. Dis. 188 2003 864 872
39. C.S. Hung, N. Vander Heyden, and L. Ratner Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization J. Virol. 73 1999 8216 8226
40. H. Tian, C. Lan, and Y.H. Chen Sequence variation and consensus sequence of V3 loop on HIV-1 gp120 Immunol. Letters 83 2002 231 233
41. W.D. Cornell, P. Cieplak, I. Bayly, I.R. Gould, K.M. Merz, and D.M. Ferguson A second-generation force field for the simulation of proteins, nucleic acids, and organic molecules J. Am. Chem. Soc. 117 1995 5179 5197
42. W.F. Vranken, M. Budesinsky, F. Fant, K. Boulez, and F.A. Borremans The complete consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solution FEBS Letters 374 1995 117 121
43. O. Hartley, P.J. Klasse, Q.J. Sattentau, and J.P. Moore V3: HIV's switch-hitter AIDS. Res. Hum. Retroviruses 21 2005 171 189
44. L. Wu, N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, and N. Ruffing CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 Nature 384 1996 179 183
45. T.L. Hoffman, C.C. LaBranche, W. Zhang, G. Canziani, J. Robinson, and I. Chaiken Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein Proc. Natl Acad. Sci. USA 96 1999 6359 6364
46. A. Trkola, T. Dragic, J. Arthos, J.M. Binley, W.C. Olson, and G.P. Allaway CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Nature 384 1996 184 187
47. P. Suphaphiphat, A. Thitithanyanont, S. Paca-Uccaralertkun, M. Essex, and T.H. Lee Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization J. Virol. 77 2003 3832 3837
48. M. Chelli, and M. Alizon Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor J. Biol. Chem. 277 2002 39388 39396
49. Q. Hu, A.P. Barry, Z. Wang, S.M. Connolly, S.C. Peiper, and M.L. Greenberg Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis J. Virol. 74 2000 11858 11872
50. Z. Lu, J.F. Berson, Y. Chen, J.D. Turner, T. Zhang, and M. Sharron Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains Proc. Natl Acad. Sci. USA 94 1997 6426 6431
51. B. Honig, and A. Nicholls Classical electrostatics in biology and chemistry Science 268 1995 1144 1149
52. A. Nicholls, K.A. Sharp, and B. Honig Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons Proteins: Struct. Funct. Genet. 11 1991 281 296